A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects
Status:
Completed
Trial end date:
2019-05-29
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the pharmacodynamic (PD) effects of
clopidogrel, prasugrel, and ticagrelor when administered after a single subcutaneous (s.c.)
dose of ACT-246475 in healthy male and female subjects